Search for: "CLINICAL DIRECTOR" Results 4141 - 4160 of 6,343
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jun 2012, 9:54 am by rmorgan
She is director of the Death Penalty Clinic at UC Berkeley School of Law. [read post]
18 Jun 2012, 7:49 pm by Stephen Jenei
By comparison, big pharma participate in 75 of projects, though Joseph pointed out that there are fewer than 20 big pharma companies and their projects are on a larger scale, spending more and running complex clinical trials in multiple countries. [read post]
18 Jun 2012, 8:00 am by Matthew L.M. Fletcher
Cantrell, Associate Professor & Director of Clinical Programs, University of Colorado Law School, Wolf Law Building, 404 UCB, Boulder, CO 80309-0404. [read post]
17 Jun 2012, 7:02 pm by David Jensen
Following the sudden abandonment last fall by Geron of its hESC business and the first-ever clinical trial of an hESC therapy, Scott and Huggett scrutinized the history of the company. [read post]
17 Jun 2012, 3:52 pm by Stephen Jenei
The focus of their audience is management level decision makers, such as the c-suite and director level, providing information regarding pre-clinical drug discovery and development up to commercialization. [read post]
16 Jun 2012, 2:00 am
Lisa LaPlante was appointed as interim director of the Thomas J. [read post]
14 Jun 2012, 11:13 am by Gordon Firemark
Palmer Center for Entrepreneurship and the Law, its Investor Advocacy Clinic Law School programs and also the University’s Center for Entertainment Media and Culture. [read post]
14 Jun 2012, 10:23 am
Sidney Wolfe, director of Public Citizen’s Health Research Group, said in a statement. [read post]
14 Jun 2012, 8:44 am by Lindsay Griffiths
They also have former medical directors of managed care plans, who help them create dossiers for new drugs and devices. [read post]
13 Jun 2012, 4:50 pm by Linda Moss
James Kelly, director of NICoE, said in a statement. [read post]
13 Jun 2012, 4:01 pm
Synthes is the leading maker of volar distal radius plating systems in the United States, accounted for 42 percent of all U.S. sales in 2010, and has a strong clinical reputation in the trauma field. [read post]
12 Jun 2012, 5:59 pm by Steve Hall
" Owen is a Visiting Clinical Professor at the Bluhm Legal Clinic, Northwestern University Law School, and Co-Director of the Death Penalty Center at the University of Texas School of Law. [read post]
12 Jun 2012, 10:43 am by William McGrath
Jun. 11, 2012) to decide whether, in a misrepresentation case under SEC Rule l0b-5, the court must require proof of materiality before certifying a plaintiff class based on the fraud-on-the-market theory (and whether the court must allow the defendants to present evidence rebutting the applicability of the fraud-on-the-market theory before certifying the class).The case was filed in federal court in California on behalf of individuals and entities who purchased shares of Amgen, Inc. between April… [read post]
12 Jun 2012, 6:04 am by James Hamilton
  According to the Boston Globe, noted the Senator, Vertex officials claim that most of the stock sales by executives and directors in the days following the disclosure of the encouraging clinical study results stemmed from preexisting Rule 10b5-1 plans that allow them to automatically exercise options and sell certain shares at regular intervals or set prices. [read post]
12 Jun 2012, 4:45 am by Tom Kosakowski
  It was written by Robert Bordone, Director of Harvard Negotiation & Mediation Clinical Program and a Public Director of the Board of Certification for Certified Organizational Ombudsman Practitioners. [read post]
12 Jun 2012, 1:36 am by Kevin LaCroix
  As discussed at greater length here, the plaintiff first sued Amgen and certain of its directors and officers in the Central District of California in April 2007. [read post]
11 Jun 2012, 7:42 pm by FDABlog HPM
  For PMAs, disagreements related to clinical trial design, the need for additional data, and appropriateness of labeling. [read post]